← FDA DRUG APPROVALS

FDA ANDA · ANDA078510

EPLERENONE

Sponsor: SANDOZ

APPLICATION
ANDA078510
TYPE
ANDA
ORIGINAL APPROVAL
2008-08-01
LATEST ACTION
2019-04-02
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

EPLERENONEPrescription
EPLERENONE 25MG · TABLET · ORAL
EPLERENONEPrescription
EPLERENONE 50MG · TABLET · ORAL

Approval history

2019-04-02Labeling · Supplement 13 · standardAP
2019-04-02Labeling · Supplement 14 · standardAP
2015-09-16Labeling · Supplement 9 · standardAP
2014-10-14Manufacturing (CMC) · Supplement 11AP
2013-02-20Labeling · Supplement 6 · standardAP
2013-02-20Labeling · Supplement 4AP
2011-05-13Labeling · Supplement 2AP
2008-08-01OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →